Table 1.
Patients' characteristics
| FNA group (n = 50) | FNB group (n = 50) | Overall (n = 100) | p | |
|---|---|---|---|---|
| Age, mean ± SD | 68 ± 11.2 | 67.8 ± 13.1 | 68.4 ± 12.5 | 0.66 |
| Gender, n (%) | 0.14 | |||
| Male | 35 (70) | 28 (56) | 63 (63) | |
| Female | 15 (30) | 22 (44) | 37 (37) | |
| Location of pancreatic mass, n (%) | 0.57 | |||
| Head | 38 (76) | 34 (68) | 72 (72) | |
| Body | 7 (14) | 11 (22) | 18 (18) | |
| Tail | 5 (10) | 5 (10) | 10 (10) | |
| Tumor size in mm, Mean ± SD | 33 ± 2.7 | 32 ± 5.1 | 32 ± 4.6 | |
| Final Diagnosis, n (%) | 0.73 | |||
| Malignancies | 43 (86) | 45 (90) | 88 (88) | |
| Adenocarcinoma | 41 (82) | 42 (84) | 83 (83) | |
| Neuroendocrine | 2 (4) | 3 (6) | 5 (5) | |
| Chronic pancreatitis | 2 (4) | 5 (10) | 7 (7) | |
| Undetermined | 5 (10) | 0 | 5 (5) | |
| After 1 year follow-up | 1 Chronic pancreatitis 2 adenocarcinomas 1 neuroendocrine tumor 1 inflammatory nodule | |||
FNA: Fine needle aspiration; FNB: fine needle biopsy; mm: millimeter; SD: standard deviation